Rating History for SAB Biotherapeutics (SABS) by Citi

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/22/2026 Samantha Semenkow New Coverage Buy
(N/A)
11.00
(N/A)
3.81
(4.00)
4.99% Details